Di-tert-butyl fumarate

Catalog No.: 
ACBCED856
CAS No.: 
7633-38-7
Molecular Formula: 
C12H20O4
Molecular Weight: 
228.29
Di-tert-butyl fumarate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$81.00In stockIn stock
5g98%$263.00In stockIn stock
25g98%$1210.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDi-tert-butyl fumarate
IUPAC Namedi-tert-butyl fumarate
MDL No.MFCD23701540
Molecular FormulaC12H20O4
Molecular Weight228.29
SMILESO=C(OC(C)(C)C)/C=C/C(OC(C)(C)C)=O
InChI KeyMSVGHYYKWDQHFV-BQYQJAHWSA-N
Synonymditert-butyl but-2-enedioate;2-Butenedioic acid (2E)-, 1,4-bis(1,1-dimethylethyl) ester;2-Butenedioic acid (2E)-, bis(1,1-dimethylethyl) ester;ditert-butyl (E)-but-2-enedioate
CAS No.7633-38-7
PubChem CID5965155

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBCED856 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHVKO425 route compound structure diagram
    ACHVKO425135355-96-3In Stock
  4. Then
  5. ACBCED856 route product structure diagram
    ACBCED8567633-38-7In Stock
Inquiry

2. ACBCED856 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBCED856 route product structure diagram
    ACBCED8567633-38-7In Stock
Inquiry

3. ACBCED856 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBCED856 route product structure diagram
    ACBCED8567633-38-7In Stock
Inquiry

Comments (0)